The AGL42 gene (also known as FYF) is a transcription factor that modulates senescence-related genes in plants. In cotton (Gossypium hirsutum), overexpression of AGL42 delays premature leaf senescence by repressing senescence-promoting NAC transcription factors and enhancing photosynthesis .
Key Findings on AGL42 in Cotton:
| Parameter | AGL42 Transgenic Cotton | Non-Transgenic Control | 
|---|---|---|
| Senescence-related gene expression | ↓ NAC8, NAC9, NAC12, NAC14, NAC17 | ↑ Expression | 
| Chlorophyll content under drought | +63% retention | 20% retention | 
| Photosynthetic rate under drought | +50% improvement | 18% improvement | 
| Boll count | Higher due to retained floral buds | Lower | 
Protein-DNA Interaction: AGL42 binds to CArG sequences in promoters of senescence genes via conserved ILE199 and ASP200 residues in its IDLNL repressor domain .
Tissue-Specific Expression: Strongest expression in petals, abscission zones, and mature leaves .
While no "AGL42 antibody" exists in the literature, antibodies targeting related biological processes or proteins are well-documented:
No specific antibodies for AGL42 are reported, but plant senescence studies often use antibodies against:
NAC Transcription Factors: Key drivers of senescence (e.g., NAC8, NAC9) .
Chlorophyll Degradation Enzymes: Such as pheophorbide a oxygenase (PAO) .
Examples from unrelated studies highlight antibody applications:
| Antibody | Target | Application | 
|---|---|---|
| 42B1 | Agalactosyl IgG | Diagnosing chronic inflammation (e.g., IBD, liver disease) | 
| 1A7/6G7 | EBV gp42 C-type lectin | Neutralizing EBV infection in B cells | 
The term "AGL42 Antibody" may stem from confusion with:
AGL42 Gene Constructs: Recombinant plasmids (e.g., AtAGL42 fused with GUS) used to track gene expression in transgenic plants .
Antibody Naming Conventions: Antibodies often include numerical identifiers (e.g., 42B1, 2B7), but these refer to clone numbers, not target proteins.
AGL42-Specific Antibodies: Development of anti-AGL42 antibodies could enable immunodetection of AGL42 protein in plants, aiding studies on senescence regulation.
Cross-Species Applications: Insights from plant transcription factors like AGL42 may inform antibody-based strategies in human diseases (e.g., targeted therapies for senescence-related disorders).